Five Trees Medical Ltd 16403906 false 2025-04-23 2026-04-30 2026-04-30 The principal activity of the company is is that of medical imaging analysis. Digita Accounts Production Advanced 6.30.9574.0 true 16403906 2025-04-23 2026-04-30 16403906 2026-04-30 16403906 core:CurrentFinancialInstruments core:WithinOneYear 2026-04-30 16403906 bus:Micro-entities 2025-04-23 2026-04-30 16403906 bus:AuditExemptWithAccountantsReport 2025-04-23 2026-04-30 16403906 bus:FilletedAccounts 2025-04-23 2026-04-30 16403906 bus:SmallCompaniesRegimeForAccounts 2025-04-23 2026-04-30 16403906 bus:RegisteredOffice 2025-04-23 2026-04-30 16403906 bus:Director1 2025-04-23 2026-04-30 16403906 bus:Director2 2025-04-23 2026-04-30 16403906 bus:PrivateLimitedCompanyLtd 2025-04-23 2026-04-30 16403906 bus:Agent1 2025-04-23 2026-04-30 16403906 countries:AllCountries 2025-04-23 2026-04-30 iso4217:GBP xbrli:pure

Registration number: 16403906

Five Trees Medical Ltd

Unaudited Filleted Financial Statements

for the Period from 23 April 2025 to 30 April 2026

 

Five Trees Medical Ltd

Contents

Company Information

1

Balance Sheet

2

Notes to the Unaudited Financial Statements

2

 

Five Trees Medical Ltd

Company Information

Directors

Dr Elias Nerad

Miss Kirsty Lee Fenn

Registered office

71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

Accountants

Simple Taxes Ltd
Chartered Certified AccountantsPiccadilly Business Centre
Unit C Aldow Enterprise Park
Manchester
Greater Manchester
M12 6AE

 

Five Trees Medical Ltd

(Registration number: 16403906)
Balance Sheet as at 30 April 2026

2026
£

Current assets

713

Creditors: Amounts falling due within one year

(572)

 

141

Capital and reserves

141

1

General information

The company is a private company limited by share capital, incorporated in UK.

The address of its registered office is:
71-75 Shelton Street
Covent Garden
London
WC2H 9JQ

These financial statements were authorised for issue by the Board on 10 June 2026.

2

Staff numbers

The average number of persons employed by the company (including directors) during the period, was 2.

For the financial period ending 30 April 2026 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the period in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the provisions applicable to companies subject to the micro entities regime and delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 10 June 2026 and signed on its behalf by:
 

.........................................
Dr Elias Nerad
Director